Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts

Clinical and Vaccine Immunology

Volumn 16, Issue 12, 2009, Pages 1774-1780

  Coelho, Eduardo A F ^a   Ramírez, Laura ^b   Costa, Mariana A F ^a   Coelho, Vinicio T S ^a   Martins, Vivian T ^a   Chávez Fumagalli, Miguel A ^a   Oliveira, Dulcilene M ^a   Tavares, Carlos A P ^a   Bonay, Pedro ^b   Nieto, Carlos Gómez ^c   Abánades, Daniel R ^b   Alonso, Carlos ^b   Soto, Manuel ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; LEISHMANIA RIBOSOME PROTEIN; LEISHMANIA VACCINE; LEISHMUNE VACCINE; LEISHTEC VACCINE; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BLOOD SAMPLING; BRAZIL; CANINE VISCERAL LEISHMANIASIS; CHAGAS DISEASE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS REACTION; CYTOSOL; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; LEISHMANIA; LEISHMANIA CHAGASI; LEISHMANIA INFANTUM; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PURIFICATION; RIBOSOME; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; SYMPTOM; VISCERAL LEISHMANIASIS;

EID: 73449109510     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00295-09     Document Type: Article

References (49)

1. Aisa, M. J., S. Castillejo, M. Gallego, R. Fisa, M. C. Riera, M. de Colmenares, S. Torras, X. Roura, J. Sentis, and M. Portus. 1998. Diagnostic potential of Western blot analysis of sera from dogs with leishmaniasis in endemic areas and significance of the pattern. Am. J. Trop. Med. Hyg. 58:154-159.
2. Alvar, J., C. Canavate, R. Molina, J. Moreno, and J. Nieto. 2004. Canine leishmaniasis. Adv. Parasitol. 57:1-88.
3. Badaro, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. Netto, D. Pedral-Sampaio, C. Madureira, J. M. Burns, R. L. Houghton, J. R. David, and S. G. Reed. 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173:758-761.
4. Baneth, G., A. F. Koutinas, L. Solano-Gallego, P. Bourdeau, and L. Ferrer. 2008. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 24:324-330.
5. Barbiéri, C. L. 2006. Immunology of canine leishmaniasis. Parasite Immunol. 28:329-337.
6. Barbosa-De-Deus, R., M. L. Dos Mares-Guia, A. Z. Nunes, K. M. Costa, R. G. Junqueira, W. Mayrink, O. Genaro, and C. A. Tavares. 2002. Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 9:1361-1366.
7. Boarino, A., A. Scalone, L. Gradoni, E. Ferroglio, F. Vitale, R. Zanatta, M. G. Giuffrida, and S. Rosati. 2005. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 12:647-653.
8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
9. Cabrera, G. P., V. O. Da Silva, R. T. Da Costa, A. B. Reis, W. Mayrink, O. Genaro, and C. B. Palatnik-de-Sousa. 1999. The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil. Am. J. Trop. Med. Hyg. 61:296-301.
10. Carcelen, J., V. Iniesta, J. Fernandez-Cotrina, F. Serrano, J. C. Parejo, I. Corraliza, A. Gallardo-Soler, F. Maranon, M. Soto, C. Alonso, and C. Gomez-Nieto. 2009. The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. Vaccine 27:5964-5973.
11. Cardoso, L., H. D. Schallig, A. Cordeiro-da-Silva, M. Cabral, J. M. Alunda, and M. Rodrigues. 2007. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs. Vet. Immunol. Immunopathol. 117:35-41.
12. Cardoso, L., H. D. Schallig, F. Neto, N. Kroon, and M. Rodrigues. 2004. Serological survey of Leishmania infection in dogs from the municipality of Peso da Regua (Alto Douro, Portugal) using the direct agglutination test (DAT) and fast agglutination screening test (FAST). Acta Trop. 91:95-100.
13. Carvalho, F. A., H. Charest, C. A. Tavares, G. Matlashewski, E. P. Valente, A. Rabello, R. T. Gazzinelli, and A. P. Fernandes. 2002. Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn. Microbiol. Infect. Dis. 43:289-295.
14. Chang, K. P., and B. S. McGwire. 2002. Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol. Dis. 1:1.
15. Chang, K. P., S. G. Reed, B. S. McGwire, and L. Soong. 2003. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop. 85:375-390.
16. Ciaramella, P., G. Oliva, R. D. Luna, L. Gradoni, R. Ambrosio, L. Cortese, A. Scalone, and A. Persechino. 1997. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet. Rec. 141:539-543.
17. Coelho, E. A., C. A. Tavares, F. A. Carvalho, K. F. Chaves, K. N. Teixeira, R. C. Rodrigues, H. Charest, G. Matlashewski, R. T. Gazzinelli, and A. P. Fernandes. 2003. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect. Immun. 71:3988-3994.
18. da Costa-Val, A. P., R. R. Cavalcanti, N. de Figueiredo Gontijo, M. S. Michalick, B. Alexander, P. Williams, and M. N. Melo. 2007. Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity. Vet. J. 174:636-643.
19. Fernandes, A. P., M. M. Costa, E. A. Coelho, M. S. Michalick, E. de Freitas, M. N. Melo, W. Luiz Tafuri, M. Resende Dde, V. Hermont, F. Abrantes Cde, and R. T. Gazzinelli. 2008. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 26:5888-5895.
20. Ferreira, W. A., W. Mayrink, M. L. dos Mares-Guia, and C. A. Tavares. 2003. Detection and characterization of leishmania antigens from an American cutaneous leishmaniasis vaccine for diagnosis of visceral leishmaniasis. Diagn. Microbiol. Infect. Dis. 45:35-43.
21. Ferreira Ede, C., M. de Lana, M. Carneiro, A. B. Reis, D. V. Paes, E. S. da Silva, H. Schallig, and C. M. Gontijo. 2007. Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations. Vet. Parasitol. 146:235-241.
22. Garcia-Alonso, M., C. G. Nieto, A. Blanco, J. M. Requena, C. Alonso, and I. Navarrete. 1996. Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system. Parasite Immunol. 18:539-546.
23. Gomes, Y. M., M. Paiva Cavalcanti, R. A. Lira, F. G. Abath, and L. C. Alves. 2008. Diagnosis of canine visceral leishmaniasis: biotechnological advances. Vet. J. 175:45-52.
24. Goto, Y., L. Y. Bogatzki, S. Bertholet, R. N. Coler, and S. G. Reed. 2007. Protective immunization against visceral leishmaniasis using Leishmania sterol 24-C-methyltransferase formulated in adjuvant. Vaccine 25:7450-7458.
25. Goto, Y., R. F. Howard, A. Bhatia, J. Trigo, M. Nakatani, E. M. Netto, and S. G. Reed. 2009. Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs. Vet. Parasitol. 160:215-220.
26. Gramiccia, M., and L. Gradoni. 2005. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35:1169-1180.
27. Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354:1191-1199.
28. Iborra, S., N. Parody, D. R. Abanades, P. Bonay, D. Prates, F. O. Novais, M. Barral-Netto, C. Alonso, and M. Soto. 2008. Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes Infect. 10:1133-1141.
29. Kar, K. 1995. Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol. 21:123-152.
30. Kubar, J., and K. Fragaki. 2005. Recombinant DNA-derived Leishmania proteins: from the laboratory to the field. Lancet Infect. Dis. 5:107-114.
31. Maalej, I. A., M. Chenik, H. Louzir, A. Ben Salah, C. Bahloul, F. Amri, and K. Dellagi. 2003. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68:312-320.
32. Mauricio, I. L., J. R. Stothard, and M. A. Miles. 2000. The strange case of Leishmania chagasi. Parasitol. Today 16:188-189.
33. Michalsky, E. M., M. F. Rocha, A. C. da Rocha Lima, J. C. Franca-Silva, M. Q. Pires, F. S. Oliveira, R. S. Pacheco, S. L. dos Santos, R. A. Barata, A. J. Romanha, C. L. Fortes-Dias, and E. S. Dias. 2007. Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies. Vet. Parasitol. 147:67-76.
34. Miro, G., L. Cardoso, M. G. Pennisi, G. Oliva, and G. Baneth. 2008. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two. Trends Parasitol. 24:371-377.
35. Miro, G., A. Montoya, M. Mateo, A. Alonso, S. Garcia, A. Garcia, M. J. Caballero, and R. Molina. 2007. A leishmaniosis surveillance system among stray dogs in the region of Madrid: ten years of serodiagnosis (1996-2006). Parasitol. Res. 101:253-257.
36. Molina, R., C. Amela, J. Nieto, M. San-Andres, F. Gonzalez, J. A. Castillo, J. Lucientes, and J. Alvar. 1994. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans. R. Soc. Trop. Med. Hyg. 88:491-493.
37. Nieto, C. G., I. Navarrete, M. A. Habela, F. Serrano, and E. Redondo. 1992. Pathological changes in kidneys of dogs with natural Leishmania infection. Vet. Parasitol. 45:33-47.
38. Otranto, D., P. Paradies, D. de Caprariis, D. Stanneck, G. Testini, F. Grimm, P. Deplazes, and G. Capelli. 2009. Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. Clin. Vaccine Immunol. 16:337-343.
39. Palatnik-de-Sousa, C. B. 2008. Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 26:1709-1724.
40. Palatnik-de-Sousa, C. B., W. R. dos Santos, J. C. Franca-Silva, R. T. da Costa, A. B. Reis, M. Palatnik, W. Mayrink, and O. Genaro. 2001. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am. J. Trop. Med. Hyg. 65:510-517.
41. Pollock, K. G., K. S. McNeil, J. C. Mottram, R. E. Lyons, J. M. Brewer, P. Scott, G. H. Coombs, and J. Alexander. 2003. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J. Immunol. 170: 1746-1753.
42. Porrozzi, R., M. V. Santos da Costa, A. Teva, A. Falqueto, A. L. Ferreira, C. D. dos Santos, A. P. Fernandes, R. T. Gazzinelli, A. Campos-Neto, and G. Grimaldi, Jr. 2007. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin. Vaccine Immunol. 14:544-548.
43. Rafati, S., A. Nakhaee, T. Taheri, A. Ghashghaii, A. H. Salmanian, M. Jimenez, M. Mohebali, S. Masina, and N. Fasel. 2003. Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp. Parasitol. 103:143-151.
44. Reed, S. G., W. G. Shreffler, J. M. Burns, Jr., J. M. Scott, G. Orge Mda, H. W. Ghalib, M. Siddig, and R. Badaro. 1990. An improved serodiagnostic procedure for visceral leishmaniasis. Am. J. Trop. Med. Hyg. 43:632-639.
45. Reis, A. B., A. Teixeira-Carvalho, A. M. Vale, M. J. Marques, R. C. Giunchetti, W. Mayrink, L. L. Guerra, R. A. Andrade, R. Correa-Oliveira, and O. A. Martins-Filho. 2006. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 112:102-116.
46. Requena, J. M., C. Alonso, and M. Soto. 2000. Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol. Today 16:246-250.
47. Silvestre, R., N. Santarem, J. Cunha, L. Cardoso, J. Nieto, E. Carrillo, J. Moreno, and A. Cordeiro-da-Silva. 2008. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry. Vet. Parasitol. 158:23-30.
48. Soto, M., L. Ramírez, M. Pineda, V. González, P. Entringer, C. Indiani de Oliveira, I. Nascimento, A. Souza, L. Corvo, C. Alonso, P. Bonay, C. Brodskyn, A. Barral, M. Barral-Netto, and S. Iborra. 2009. Searching genes encoding Leishmania antigens for diagnosis and protection. Scholarly Research Exchange, article identifier, 173039. doi: 10.3814/2009/173039.
49. Soto, M., J. M. Requena, L. Quijada, and C. Alonso. 1998. Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J. Clin. Microbiol. 36:58-63.